Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: J Immunol. 2013 Apr 3;190(9):4650–4660. doi: 10.4049/jimmunol.1202120

Table V.

2DS1pos C1:C1 NK clones co-expressing inhibitory KIR for self-HLA-class I

Donor HLA-C genotype KIR phenotype Target HLA-C genotype n Cytolytic
p
Yes, n (%) No, n (%)
C1:C1 2DS1 and 2DL2/3 C2:C2;Bw4 46 42 (91) 4 (9) <0.0001a
C1:C2;Bw4 1 (5) 18 (95)
C1:C1 2DS1 and 3DL1 C2:C2;Bw4 2 0 (0) 2 (100)
a

Frequency of cytolytic clones to targets with different HLA-C genotype is compared.